Sanara MedTech Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.02 | $0.05 | +150.0% | Beat |
| Q12026 FY2026 | $-0.04 | $0.04 | +200.0% | Beat |
| Q42025 FY2025 | $0.11 | $0.04 | -63.6% | Miss |
Back to SMTI overview · SMTI holders · SMTI KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.